Texture analysis in contrast enhanced CT: New method to predict prognosis of small cell lung cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Wang, M. [1 ]
Ma, X. [1 ]
机构：
[1] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26P
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
  • [42] Chemotherapy-induced leukopenia as a prognostic factor in patients with metastatic non-small cell lung cancer treated with platinum-based chemotherapy
    Huang, Aimi
    Ma, Meili
    Jin, Bo
    Han, Baohui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 5241 - 5248
  • [43] Cetuximab-added platinum-based chemotherapy: a new treatment option for non-small-cell lung cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (02) : 120 - 121
  • [44] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Hirotsugu Kenmotsu
    Tateaki Naito
    Keita Mori
    Ryo Ko
    Akira Ono
    Kazushige Wakuda
    Hisao Imai
    Tetsuhiko Taira
    Haruyasu Murakami
    Masahiro Endo
    Toshiaki Takahashi
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 521 - 526
  • [45] Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block
    Hockenhull, Kimberley
    Ortega-Franco, Ana
    Califano, Raffaele
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (09) : 3850 - 3854
  • [46] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Mori, Keita
    Ko, Ryo
    Ono, Akira
    Wakuda, Kazushige
    Imai, Hisao
    Taira, Tetsuhiko
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 521 - 526
  • [47] Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy
    Liu, Jun-Yan
    Zou, Ting
    Yin, Ji-Ye
    Wang, Zhan
    Wang, Ying
    Liu, Zhao-Qian
    Chen, Juan
    Chen, Zhi-Wei
    JOURNAL OF CANCER, 2020, 11 (18): : 5281 - 5288
  • [48] Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer
    Wan Zhao
    Lingmin Hu
    Jiali Xu
    Hongbing Shen
    Zhibin Hu
    Hongxia Ma
    Yongqian Shu
    Yongfeng Shao
    Yongmei Yin
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1287 - 1295
  • [49] Association of variations in the Fanconi anemia complementation group and prognosis in Non-small cell lung cancer patients with Platinum-based chemotherapy
    Mo, Jun-Luan
    Liu, Jia-Si
    Xiao, Qi
    Hong, Wen-Xu
    Yin, Ji-Ye
    Chen, Juan
    Liu, Zhao-Qian
    GENE, 2022, 825
  • [50] Pretreatment Inflammatory Indexes are Associated with Response to First-Line Platinum-Based Chemotherapy and Prognosis of Small Cell Lung Cancer Patients
    Inanc, Mevlude
    Bozkurt, Oktay
    Ocak Duran, Ayse
    Ozkan, Metin
    Altinbas, Mustafa
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (02): : 79 - 87
12345